Purdue Pharma to Dissolve Following $225 Million Criminal Sentence for Opioid Crisis Role
Here's what it means for you.
This landmark ruling signals a shift towards greater accountability in the pharmaceutical industry.
What happened
A federal judge approved a $225 million criminal sentence for Purdue Pharma, leading to the company's dissolution.
The Context
- Purdue Pharma has faced numerous lawsuits for its role in the opioid crisis.
- The $225 million payment is part of a settlement with the U.S. Department of Justice.
- A new company will be established to focus on combating the opioid epidemic.
Takeaway
The dissolution of Purdue Pharma signals a significant shift in the pharmaceutical landscape regarding accountability for opioid-related issues.
Top international stories selected by The Guardian editors.
"The Guardian is known for its progressive editorial stance and in-depth analysis."
— A47 Editor
Purdue Pharma to be dissolved as judge approves criminal sentence in opioid case
Purdue Pharma, the maker of OxyContin, is set to be dissolved and replaced by a new company focused on addressing the opioid crisis, following a federal judge's approval of a criminal sentence related to a US Department of Justice investigation. This...
Coverage of national news and events from across the United States.
"HuffPost is known for its progressive editorial stance, offering opinionated yet comprehensive coverage on social, political, and cultural topics."
— A47 Editor
OxyContin Maker Purdue Pharma Set To Dissolve After Judge Approves Its Criminal Sentence
Purdue Pharma, the maker of OxyContin, has been ordered by a federal judge to pay $225 million to the U.S. Justice Department, concluding a lengthy criminal case tied to the company's role in the opioid epidemic. This ruling marks a significant step ...
Public health, medical research, healthcare policy, and pharmaceutical developments.
"Dow Jones is a major financial news provider with a professional tone and broad coverage, including specialized health-sector reporting."
— A47 Editor
A federal judge sentenced OxyContin-maker Purdue Pharma to pay the government $225 million, ending a yearslong criminal case involving the company accused of fueling the opioid epidemic
Purdue Pharma has been ordered to pay $225 million to the U.S. Justice Department, concluding a lengthy criminal case linked to the company's role in the opioid epidemic. This ruling allows Purdue to finalize a settlement related to numerous lawsuits...
Coverage of national news and issues shaping the United States, including politics, economy, and society.
"The Wall Street Journal is one of the most respected financial and news publications in the U.S., known for its rigorous reporting and center-right editorial perspective."
— A47 Editor
Purdue Pharma to Pay $225 Million to Justice Department
Purdue Pharma has been ordered to pay $225 million to the U.S. Justice Department, concluding a lengthy criminal case linked to the company's role in the opioid epidemic. This ruling allows Purdue to finalize a settlement related to numerous lawsuits...
Markets desk coverage, trading insights, and investor updates.
"WSJ’s markets reporting provides in-depth analysis and context for investors."
— A47 Editor
Purdue Pharma to Pay $225 Million to Justice Department
Purdue Pharma has been ordered to pay $225 million to the Justice Department, concluding a lengthy criminal case linked to the company's role in the opioid epidemic. This ruling allows Purdue to finalize a settlement related to numerous lawsuits rega...